Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia – a case report

Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia – a case report

Bibliographic Details
Main Authors:	Eduardo Atsushi Osawa, Antonio Adolfo Guerra Soares Brandão, André Dias Américo, Alexandre Toledo Maciel
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S253113792030081X

Similar Items

Fondaparinux monitoring in a patient with heparin-induced thrombocytopenia on hemodialysis
by: Kušić Jovana, et al.
Published: (2016-01-01)

Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation
by: Andreas Margraf, et al.
Published: (2022-06-01)

Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol
by: Dania Ghaziri, et al.
Published: (2023-01-01)

Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban
by: Farheen Manji, et al.
Published: (2020-01-01)

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review
by: Amy Christopher
Published: (2016-12-01)

Successful use of fondaparinux for perioperative bridging in a patient with a mechanical heart valve and heparin-induced thrombocytopenia
by: C R Pruthvi, et al.
Published: (2019-01-01)

Can this be considered a Fondaparinux-induced Thrombocytopenia?
by: Barbara Mariotti, et al.
Published: (2014-04-01)

Comparative evaluation of the methods of continuous hemodiafiltration and hemofiltration with citrate anticoagulation in cardiac surgery patients
by: А. С. Борисов, et al.
Published: (2015-10-01)

Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
by: Jonathan S. Williams, et al.
Published: (2018-01-01)

Use of fondaparinux in patients with heparin-induced thrombocytopenia on veno-venous extracorporeal membrane oxygenation: A three-patient case series report
by: Jitka Rychlíčková, et al.
Published: (2023-02-01)

Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
by: Lorenzo A. Alberio, et al.
Published: (2020-04-01)

Contribution of novel anticoagulants fondaparinux and dabigatran to venous thromboembolism prevention
by: Antonijević Nebojša, et al.
Published: (2015-01-01)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
by: Alex C Spyropoulos, et al.
Published: (2008-06-01)

Living kidney transplantation without perioperative anticoagulation therapy for a patient with heparin‐induced thrombocytopenia
by: Hayato Nishida, et al.
Published: (2020-05-01)

Fondaparinux
by: G. Airoldi, et al.
Published: (2013-05-01)

Silver-assisted gold-catalyzed formal synthesis of the anticoagulant Fondaparinux pentasaccharide
by: Gulab Walke, et al.
Published: (2021-02-01)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
by: Fakiha Siddiqui BDS, et al.
Published: (2020-01-01)

The challenge of removal of sepsis markers by continuous hemofiltration
by: Patrick M. Honore, et al.
Published: (2019-05-01)

How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation
by: Antoine Barocas, et al.
Published: (2023-09-01)

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
by: Shimizu K, et al.
Published: (2018-02-01)

Heparin-induced thrombocytopenia
by: Prakash Shastri, et al.
Published: (2021-01-01)

HEPARIN INDUCED THROMBOCYTOPENIA
by: Matija Kozak, et al.
Published: (2008-03-01)

Heparin-induced thrombocytopenia
by: Shaikh Nissar
Published: (2011-01-01)

PERBANDINGAN KUALITAS HIDUP PENDERITA SINDROMA KORONER AKUT DENGAN TERAPI HEPARIN DAN FONDAPARINUX
by: , KUSUMAWARDHANI ANDANASARI, et al.
Published: (2013)

Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion
by: Long Zhao, et al.
Published: (2021-10-01)

Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
by: Paul Köglberger, et al.
Published: (2021-04-01)

Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study.
by: Yan Yu, et al.
Published: (2020-01-01)

Effect of fondaparinux on viability and ischemia reperfusion injury in the abdominal perforator flap
by: Guler Gamze Eren Ozcan, et al.
Published: (2020-01-01)

Continuous Venovenous Hemofiltration in Complex Treatment for Generalized Peritonitis
by: O. M. Shevtsova, et al.
Published: (2008-02-01)

Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients
by: Paraskevi C. Fragkou, et al.
Published: (2022-05-01)

Autoimmune Heparin-Induced Thrombocytopenia
by: Theodore E. Warkentin
Published: (2023-11-01)

HEPARIN-INDUCED THROMBOCYTOPENIA (REVIEW)
by: S. A. Vasiliev, et al.
Published: (2019-06-01)

Heparin-induced thrombocytopenia: an update
by: Franchini Massimo
Published: (2005-10-01)

Direct Oral Anticoagulants as Successful Treatment of Heparin-Induced Thrombocytopenia: A Parisian Retrospective Case Series
by: Julie Carré, et al.
Published: (2021-08-01)

Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approach
by: Abdel-Razeq H, et al.
Published: (2011-06-01)

Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome
by: Julie Carré, et al.
Published: (2021-12-01)

Bioenergetic Balance of Continuous Venovenous Hemofiltration, a Retrospective Analysis
by: Joop Jonckheer, et al.
Published: (2022-05-01)

Fondaparinux versus Enoxaparin - Which is the Best Anticoagulant for Acute Coronary Syndrome? - Brazilian Registry Data
by: Alexandre de Matos Soeiro, et al.
Published: (2016-01-01)

Acute limb ischemia secondary to vaccine-induced thrombotic thrombocytopenia
by: Bowen Xie, et al.
Published: (2023-03-01)

Assumption of heparin-induced thrombocytopenia in mucopolysaccharidoses
by: Liliya Aleksandrovna Osipova, et al.
Published: (2021-08-01)